Vitamin D Levels in Women With Polycystic Ovary Syndrome

Phase 4

Completed

• Conditions: Polycystic Ovary Syndrome
• Interventions: Drug: Vitamin D Levels measurement using chemiluminescent assay; Device: Vitamin D level assessment

• Registration Number: NCT05101811
• Lead Sponsor: Ghamra Military Hospital

Brief Summary

Polycystic ovary syndrome is the commonest endocrinopathy among women of reproductive age. Its worldwide prevalence has been estimated between5-10%.

Vitamin D, a fat-soluble vitamin, can be produced in two ways: by intestinal absorption and endogenous synthesis from a precursor of 17-hydroxyl cholesterol on the skin with sufficient exposure to ultraviolet sunlight.

Detailed Description

The aim of this work is assessment of the level of vitamin D in female have polycystic ovary syndrome \& healthy female.and also make diagnostic criteria for patient who is in need for supplementations with vitamin D.

Study Timeline

• Study Start: 2020-05-01
• Primary Completion: 2021-04-01
• Study Completion: 2021-05-01
• Status Verified: 2021-10
• Study First Submitted: 2021-10-08
• Study First Submitted QC: 2021-10-21
• Last Update Submitted: 2021-10-21
• Study First Posted: 2021-11-01
• Last Update Posted: 2021-11-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 90

Inclusion Criteria

Not provided

Exclusion Criteria

• Thyroid disease
• Parathyroid disease
• Diabetes Mellitus
• Cushing syndrome
• Congenital adrenal hyperplasia
• Hyperprolactinemia
• Renal, liver or chronic disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Control women without polycystic ovary syndrome	Vitamin D Levels measurement using chemiluminescent assay	Normal fertile women without polycystic ovary syndrome
Control women without polycystic ovary syndrome	Vitamin D level assessment	Normal fertile women without polycystic ovary syndrome
Case women with polycystic ovary syndrome	Vitamin D Levels measurement using chemiluminescent assay	Women with polycystic ovary syndrome
Case women with polycystic ovary syndrome	Vitamin D level assessment	Women with polycystic ovary syndrome

Primary Outcome Measures

Name	Time	Method
Levels of vitamin D in Polycystic ovary syndrome	1 year	vitamin D levels is assumed to be significantly decreased

Secondary Outcome Measures

Name	Time	Method
Levels of vitamin D in fertile women	1 year	vitamin D level is expected to be normal

Trial Locations

Locations (1)

Misr Al Gadida Military hospital; 🇪🇬 Cairo, Egypt